Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9f573b0cf32bad7ae65d621d1c142808 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-05 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C209-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C233-65 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C231-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C231-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B59-001 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K101-02 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B59-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C231-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C233-65 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-04 |
filingDate |
2016-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_273b6a26ef4851d9a2b2ae06ff7f53e9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_29ef939e61392bc43d9781558bc5bdf8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7809068042ffdcf588a304d4587d247a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_01333444cf04748fc2d40f85bdffd932 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d563c2f334079015c8e5759aeafcd217 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_549bfe2991cedfff6c407c8c18122484 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b47d957c59d339c41a0cef11f44d107 |
publicationDate |
2017-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CN-106496062-A |
titleOfInvention |
A kind of PET imaging agent and preparation method thereof |
abstract |
The invention provides a PET imaging agent and a preparation method thereof. The molecular formula of PET imaging agent is: The imaging agent of the invention can be used in the fields of diabetic brain-related and neurodegenerative diseases, as a molecular probe for studying DM complicated by AD pathology, and can be used for PET imaging of diabetes-related brain and Alzheimer's disease. |
priorityDate |
2016-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |